{"altmetric_id":2777531,"counts":{"readers":{"mendeley":8,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":3,"unique_users":["707809739","202969119794991","142212602616650"],"posts_count":3},"total":{"posts_count":5},"twitter":{"unique_users_count":2,"unique_users":["Flavio58","CancerCureNow"],"posts_count":2}},"selected_quotes":["Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft mode"],"citation":{"altmetric_jid":"4f6fa6113cf058f610006efa","authors":["Thomas Van Looy","Agnieszka Wozniak","Giuseppe Floris","Raf Sciot","Haifu Li","Jasmien Wellens","Vanleeuw Ulla","Jonathan A Fletcher","Paul W. Manley","Maria Debiec-Rychter","Patrick Schoffski"],"doi":"10.1158\/1078-0432.ccr-14-1823","first_seen_on":"2014-10-15T11:51:32+00:00","issns":["1557-3265"],"journal":"Clinical Cancer Research","last_mentioned_on":1417414231,"links":["http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/11\/1078-0432.CCR-14-1823.abstract?papetoc=","http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/11\/1078-0432.CCR-14-1823.abstract","http:\/\/clincancerres.aacrjournals.org\/content\/20\/23\/6071.short?rss=1","http:\/\/clincancerres.aacrjournals.org\/cgi\/content\/short\/20\/23\/6071?rss=1","http:\/\/m.clincancerres.aacrjournals.org\/content\/early\/2014\/10\/11\/1078-0432.CCR-14-1823.abstract?papetoc"],"pdf_url":"http:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/11\/1078-0432.CCR-14-1823.full.pdf","pmid":"25316817","pubdate":"2014-10-13T23:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"title":"Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumours: rationale and efficacy.","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/phosphoinositide-3kinase-inhibitors-combined-imatinib-patientderived-xenograft-models-gastrointestin"},"altmetric_score":{"score":1.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":4570588,"mean":5.3808397682165,"rank":2041224,"this_scored_higher_than_pct":52,"this_scored_higher_than":2419673,"rank_type":"exact","sample_size":4570588,"percentile":52},"similar_age_3m":{"total_number_of_other_articles":121668,"mean":8.6213096566859,"rank":51394,"this_scored_higher_than_pct":54,"this_scored_higher_than":66209,"rank_type":"exact","sample_size":121668,"percentile":54},"this_journal":{"total_number_of_other_articles":4000,"mean":3.7407601900475,"rank":2002,"this_scored_higher_than_pct":46,"this_scored_higher_than":1874,"rank_type":"exact","sample_size":4000,"percentile":46},"similar_age_this_journal_3m":{"total_number_of_other_articles":77,"mean":7.3868157894737,"rank":62,"this_scored_higher_than_pct":12,"this_scored_higher_than":10,"rank_type":"exact","sample_size":77,"percentile":12}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":3,"Student  > Ph. D. Student":2,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":5,"Agricultural and Biological Sciences":3}}},"geo":{"twitter":{"IT":1},"mendeley":{"BE":1}}},"posts":{"facebook":[{"title":"Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models...","url":"https:\/\/www.facebook.com\/707809739\/posts\/928118927215782","license":"public","citation_ids":[2777531],"posted_on":"2014-10-16T09:50:53+00:00","summary":"Can anyone access this paper?:\n\nhttp:\/\/clincancerres.aacrjournals.org\/content\/early\/2014\/10\/11\/1078-0432.CCR-14-1823.abstract\n\nThanks clincancerres.aacrjournals.org","author":{"name":"An Thys","url":"https:\/\/www.facebook.com\/707809739","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/707809739\/picture","id_on_source":"707809739"}},{"title":"Phosphoinositide 3-Kinase Inhibitors Combined with Imatinib in Patient-Derived Xenograft Models...","url":"https:\/\/www.facebook.com\/202969119794991\/posts\/722067287885169","license":"public","citation_ids":[2777531],"posted_on":"2014-12-01T06:10:31+00:00","summary":"clincancerres.aacrjournals.org","author":{"name":"News su HIV, Cancro e Salute.","url":"https:\/\/www.facebook.com\/202969119794991","facebook_wall_name":"News su HIV, Cancro e Salute.","image":"https:\/\/graph.facebook.com\/202969119794991\/picture","id_on_source":"202969119794991"}},{"title":"m.clincancerres.aacrjournals.org","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=333341670170408&id=142212602616650","license":"public","citation_ids":[2777531],"posted_on":"2014-10-16T14:19:44+00:00","author":{"name":"Rare Cancer","url":"https:\/\/www.facebook.com\/142212602616650","facebook_wall_name":"Rare Cancer","image":"https:\/\/graph.facebook.com\/142212602616650\/picture","id_on_source":"142212602616650"}}],"twitter":[{"url":"https:\/\/twitter.com\/Flavio58\/status\/539300492019761153","license":"datasift","citation_ids":[2777531],"posted_on":"2014-12-01T06:10:31+00:00","author":{"name":"Flavio Bernardotti","url":"https:\/\/www.facebook.com\/Flavio58","image":"https:\/\/pbs.twimg.com\/profile_images\/812732443987951616\/aYpgetZQ_normal.jpg","description":"On  the networks since 1985. Computer security, hacking, cracking, computer vision, AI, military spy systems (tempest), electronic. Lunatic insane.","id_on_source":"Flavio58","tweeter_id":"17228282","geo":{"lt":45,"ln":8,"country":"IT"},"followers":2000},"tweet_id":"539300492019761153"},{"url":"https:\/\/twitter.com\/CancerCureNow\/status\/522354000440483840","license":"datasift","citation_ids":[2777531],"posted_on":"2014-10-15T11:51:13+00:00","author":{"name":"Cure Cancer Now","url":"http:\/\/cancercure-d.blogspot.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1128872809\/Hep_G2_Lab_test_normal.jpg","description":"Pure science is what it is taking to defeat cancer. Follow us to be a part of history in the making. Receive only the best information here.","id_on_source":"CancerCureNow","tweeter_id":"193691326","geo":{"lt":null,"ln":null},"followers":8383},"tweet_id":"522354000440483840"}]}}